Abstract
Aim:
To investigate the pro-apoptotic effects of α-1-adrenergic inhibitor doxazosin in HeLa cells and the potential involvement of transcription factor activator protein-2α (AP-2α) in doxazosin-induced apoptosis.
Methods:
The HeLa cells were exposed to various concentrations of doxazosin for 16 h. Apoptosis was detected using a DNA fragmentation assay, Hoechst 33258 staining, and flow cytometric analysis. The expression of AP-2α and caspase-3 was detected by relative quantitative RT-PCR and Western blot assays, respectively. After the respective transfections of the HeLa cells with AP-2α overexpressing constructs and an antisense oligonucleotide against AP-2α, apoptosis was assessed by flow cytometric analysis, and the expression of AP-2α and caspase-3 was detected by relative quantitative RT-PCR and Western blot assays. The colorimetric assay was performed to detect the caspase-3 activity.
Results:
Treatment with various concentrations of doxazosin for 16 h increased the apoptotic rate and total cell death rate of the HeLa cells in a dose-dependent manner and upregulated the expression of AP-2α and caspase-3 in a dose-dependent manner. A dose-dependent increase was observed in the caspase-3 activity. Overexpressing AP-2α led to the increased rate of doxazosin-induced apoptosis and the total cell death, whereas doxazosin-induced apoptosis and the total cell death in HeLa cells decreased by antisense AP-2α. Furthermore, overexpressing AP-2α increased the expression and activity of caspase-3, whereas antisense AP-2α in part abolished the increased effects of doxazosin on caspase-3 expression and activity.
Conclusion:
Doxazosin induces apoptosis in HeLa cells in a dose-dependent manner, and transcription factor AP-2α is functionally involved in doxazosin-induced HeLa cell apoptosis.
Similar content being viewed by others
Article PDF
References
Black HR . Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertension. J Cardiovasc Pharmacol 2003; 41: 866–9.
Pool JL . Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. Am Heart J 1991; 121: 251–9.
Lowe F . α-1-Adrenoceptor blockade in the treatment of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1999; 2: 110–9.
Harris AM, Warner BW, Wilson JM, Becker A, Rowland RG, Conner W, et al. Effect of α1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study. J Urol 2007; 178: 2176–80.
Kyprianou N, Benning CM . Suppression of human prostate cancer cell growth by α 1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Cancer Res 2000; 60: 4550–5.
Kyprianou N, Chon J, Benning CM . Effects of α (1)-adrenoceptor (α(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease. Prostate 2000; 9 ( Suppl): 42–6.
Benning CM, Kyprianou N . Quinazoline-derived α 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an α1-adrenoceptor-independent action. Cancer Res 2002; 62: 597–602.
Tahmatzopoulos A, Sheng S, Kyprianou N . Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene 2005; 24: 5375–83.
Keledjian K, Kyprianou N . Anoikis induction by quinazoline-based α1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2. J Urol 2003; 169: 1150–6.
Partin JV, Anglin IE, Kyprianou N . Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IKBα induction. Br J Cancer 2003; 88: 1615–21.
Walden PD, Globina Y, Nieder A . Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase. Urol Res 2004; 32: 261–5.
Garrison JB, Kyprianou N . Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Res 2006; 66: 464–72.
Shaw YJ, Yang YT, Garrison JB, Kyprianou N, Chen CS . Pharmacological exploitation of the α1-adrenoceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation. J Med Chem 2004; 47: 4453–62.
Arencibia JM, Del Rio M, Bonnin A, Lopes R, Lemoine NR, Lopez-Barahona M . Doxazosin induces apoptosis in LNCaP prostate cancer cell line through DNA binding and DNA-dependent protein kinase down-regulation. Int J Oncol 2005; 27: 1617–23.
Fernando MA, Heaney AP . α1-Adrenergic receptor antagonists: novel therapy for pituitary adenomas. Mol Endocrinol 2005; 19: 3085–96.
Franco EL, Duarte-Franco E, Ferenczy A . Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Cmaj 2001; 164: 1017–25.
Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 1996; 381: 238–41.
Holzschuh J, Barrallo-Gimeno A, Ettl AK, Durr K, Knapik EW, Driever W . Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype. Development 2003; 130: 5741–54.
Knight RD, Javidan Y, Zhang T, Nelson S, Schilling TF . AP2-dependent signals from the ectoderm regulate craniofacial development in the zebrafish embryo. Development 2005; 132: 3127–38.
Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, et al. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 1998; 58: 5466–72.
Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J, et al. Expression of HER2 and its association with AP-2 in breast cancer. Eur J Cancer 2004; 40: 1485–95.
Odegaard E, Staff AC, Kaern J, Florenes VA, Kopolovic J, Trope CG, et al. The AP-2γ transcription factor is upregulated in advanced-stage ovarian carcinoma. Gynecol Oncol 2006; 100: 462–8.
Khattar NH, Lele SM, Kaetzel CS . Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2. J Biomed Sci 2005; 12: 65–77.
Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, et al. Loss of the AP-2α transcription factor is associated with the grade of human gliomas. Clin Cancer Res 2005; 11: 267–72.
Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, et al. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 2004; 10: 8521–30.
Tellez C, McCarty M, Ruiz M, Bar-Eli M . Loss of activator protein-2α results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J Biol Chem 2003; 278: 46632–42.
Fan WH, Karnovsky MJ . Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells. J Biol Chem 2002; 277: 9800–5.
Wajapeyee N, Somasundaram K . Cell cycle arrest and apoptosis induction by activator protein 2α (AP-2α) and the role of p53 and p21WAF1/CIP1 in AP-2α-mediated growth inhibition. J Biol Chem 2003; 278: 52093–101.
Wajapeyee N, Raut CG, Somasundaram K . Activator protein 2α status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy. Cancer Res 2005; 65: 8628–34.
Wajapeyee N, Britto R, Ravishankar HM, Somasundaram K . Apoptosis induction by activator protein 2α involves transcriptional repression of Bcl-2. J Biol Chem 2006; 281: 16 207–19.
Porter AG, Janicke RU . Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999; 6: 99–104.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported in part by the 973 project of the Ministry of Science and Technique of China (No 2005CB522505 and 2006CB0F0306), the National Natural Science Foundation of China (No 20335020 and 30470945), the Program for Changjiang Scholars and Innovative Research Team in University (No IRT0445), and the Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (No 705041).
Rights and permissions
About this article
Cite this article
Gan, L., Zhu, Dx., Yang, Lp. et al. Involvement of transcription factor activator protein-2α in doxazosin-induced HeLa cell apoptosis. Acta Pharmacol Sin 29, 465–472 (2008). https://doi.org/10.1111/j.1745-7254.2008.00780.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00780.x
Keywords
This article is cited by
-
Apoptosis induction by doxazosin and other quinazoline α1-adrenoceptor antagonists: a new mechanism for cancer treatment?
Naunyn-Schmiedeberg's Archives of Pharmacology (2009)